Tuesday, November 17, 2026

Pharmaceutical News

German Chemicals lobby warns that growth in Asia is hurting the recovery

VCI, the main lobby group for Germany's chemical industry, warned on Thursday that it expects its production, which includes pharmaceuticals, will fall by 1.5% in 2026. It also said that a weak European market and a shift in investment to Asia have undermined hopes of a sustainable recovery. The association predicted that the manufacturing sector would continue to experience a decline in output due to weak sales, rising costs, and low investment. This is a major pillar for Germany's manufacturing industry.

German chemical lobby expects production to fall again in 2026

The main German chemical lobby group VCI warned on Thursday that the industry's expectations are for a 1.5% drop in production by 2026. The association predicts another year of falling output due to weak sales, rising costs, and low investment. This sector is a major pillar in Germany's manufacturing industry. VCI reported that the chemical and pharmaceutical industry in Germany saw a 3% drop in production in 2026's first half, while sales fell by 1% to 123.4 billion euros. Prices for producers rose by 2%.

French and Benelux stocks: Factors to watch for on July 16

Here are some company news stories and articles from France and Benelux that could impact the markets in these countries or even individual stocks. The Information reported that chip?toolmaker ASML intends to raise the prices?for its chipmaking equipment despite opposition from TSMC. The French train manufacturer has signed a deal in Brazil for the installation of the signalling system in the new Maua Norte marshalling yards in the Sao Paulo metropolis. The underwater drone manufacturer won a contract from a European Navy for three light mine countermeasures systems drones.

Aiyengar, a JPMorgan analyst, sees global companies turning to China in the face of volatility

Anu 'Aiyengar, JPMorgan Global Chair of Investment Banking, said that global companies are more eager to partner with innovative Chinese companies as rising economic and geopolitical risk fuels a dealmaking explosion. Dealmakers will have another record-breaking year in 2026, as CEOs are relying on acquisitions and scale to help them weather the global volatility. Aiyengar stated that American and European companies increasingly see tie-ups between established Chinese players as being less risky in turbulent times than going it alone.

Aiyengar, a JPMorgan analyst, believes that global firms are turning to China as a refuge amid global volatility.

Anu Aiyengar, JPMorgan’s Global Chair of Investment Banking, said that global?companies were increasingly keen to partner with innovative Chinese companies as rising economic and geopolitical risks fuelled a dealmaking boom. Dealmakers will have another record-breaking year in 2026, as CEOs are relying on acquisitions and scale to deal with global volatility. Aiyengar stated that American and European companies increasingly see tie-ups between established Chinese players as being less risky than going alone in turbulent times.

Want to join the "China is back" rally? Raychaudhuri: Be careful!

Investors often repeat the phrase "China is back", pointing to the successes of the country's?artificial-intelligence companies, and its ongoing recovery from a deflationary slump of three years. Stock-picking remains difficult in China. China appears to be emerging from its slump. The first-quarter gross national product increased by 5.0% on an annual basis, compared to a low of 4.5% for the fourth quarter, mainly due to strong manufacturing and exports. The consumer spending is still patchy, and the property market continues to decline.

Ethiopia signs 13 billion dollar deals at Investment Conference

Ethiopian state investment commission announced that it had secured $13 billion in 'investment deals' after a conference to?attract capital into a range of economic sectors. The East African nation, like?other frontier economies of Africa, has sought to increase foreign direct investments, especially in manufacturing, in order to create jobs for the growing population. Kenya, the neighboring country, announced deals worth $2.9 billion last week. Ethiopia Investment Commission's (EIC) statement…

Europe's STOXX 600 closes on record high due to earnings boost. ECB shifts focus

Investors assessed corporate earnings and reports about a possible leadership change at the European Central Bank. All major regional benchmarks finished in positive territory. The pan-European Index closed 1.2% higher at 628.69. The defence sector rose 2.9%. BAE Systems added about 4%, after reporting an increase in operating profit that was better than expected, and as global demand increased its order backlog, which reached a record of 83.6 billion pounds ($113.50billion). Sector gains momentum after abrupt ending of peace talks between Ukraine & Russia.

China's biotech licensing boom will reach record levels in 2026, as pipelines swell

As global drugmakers cut costs before patents expire, they are increasing their search for China's experimental medicines. Industry analysts predict that licensing deals this year will reach a new record. According to Pharmcube, the value of such deals signed by companies within Greater China - including Hong Kong, Macau, and Taiwan – rose tenfold from 2021, to an unprecedented $137.7 Billion. Mainland China is at the forefront of this search. Global drugmakers such as Novartis Merck and GSK signed major agreements in China last year.

Sources say that during Starmer's visit, Britain and China will revive the 'Golden Era business dialogue'

Three sources familiar with this initiative have confirmed that the British and Chinese governments will be aiming to revive "golden age" business dialogues when Keir Starmer, Prime Minister of Britain, visits Beijing next Monday. Top executives from both countries are 'invited' to participate. AstraZeneca is among the British companies that will join a restructured "UK-China Chief Executive Council" according to sources who are both Chinese as well as British. The original idea for the council came from then-Prime Minster Theresa May in 2018 and then-Premier Li Keqiang…

Wall Street Journal, December 23,

These are the most popular stories from the Wall Street Journal. The Wall Street Journal has not verified these stories, and cannot vouch for the accuracy of their content. Trump's administration has suspended the leases for?five? large offshore wind farms that are currently under construction off of the U.S. East Coast due to what they called national security concerns. This sent shares in offshore wind companies plummeting. Oracle co-founder Larry Ellison personally guaranteed $40.4 billion to entice Warner Bros Discovery to stop selling its prized Hollywood assets.

VCI Germany expects the chemical industry to stagnate by 2026

VCI, the German chemicals lobby group, expects sales and orders to stagnate in 2019. This is due to high regulatory uncertainty, uncompetitive manufacturing costs and a long approval process. The ?association, which represents around 2,300 companies, said revenues in the chemical-pharmaceutical industry fell 1% to 220 billion euros ($256.26 billion) in 2025. "I don't believe that certain measures will have a significant effect in the?short term but if we don't start today…

Germany's VCI predicts a "difficult road" and a stagnant chemical industry in 2026

VCI, the German chemicals lobby, expects that orders and sales will stagnate by 2026 due to high regulatory uncertainty, uncompetitive?production costs, and slow approval process. The ?association, which represents around 1,900 companies, said revenues in the chemical-pharmaceutical industry fell 1% to 220 billion euros ($256.26 billion) in 2025. The German chemicals industry, which employs around half a million people, is under increasing pressure due to high production costs, bureaucratic burdens, and a stagnant economy. This pressure is compounded by U.S. import tariffs.

London's FTSE 100 recovers after a four-day decline; inflation data increases rate-cut bets

The FTSE 100 in London was little changed Wednesday after four sessions of falling prices. Gains in consumer staples and healthcare kept the market afloat while a slower inflation rate raised hopes for a rate cut in December. As of 12:40 GMT the blue-chip index had fallen 0.07%, while the midcap FTSE 250 was up 0.07%. The UK's inflation rate slowed for the first month since May. This is good news for the government ahead of the annual budget next week and increases the chances of a Bank of England rate cut.

The UK's FTSE100 is down as energy and industrial shares weigh

The FTSE 100 index in London dipped on Wednesday, after two sessions of record-high levels. Losses in energy and industrial shares weighed heavily on the market. Blue-chip index fell 0.1% to 9,886 as of 1214 GMT. However, it is still nearing record levels and within striking range of the 10,000 point. The mid-cap index FTSE 250 rose 0.1%. The market sentiment improved this week as investors hoped for a resolution to the U.S. Government shutdown. Investors expect that the U.S.

French and Benelux stocks: Factors to watch

Here are some company news and stories that could impact the markets in France and Benelux or even individual stocks. Aedifica: The healthcare real estate company Aedifica announced that its nine-month rental revenue rose by 8%, to 271.8 millions euros. It also raised the EPRA estimate for earnings per share in full-year to 5.10 euros. ASM INTERNATIONAL Semiconductor Equipment Maker ASM International reported Q3 revenues of 800 million euro with a net income of 384.1 millions euros. Orders totaled 636.8million euros.

Eni wants to build a biorefinery and recycling plant in Sicily

Eni, an Italian energy company, announced on Thursday that it has begun the environmental approval process for the transformation of its industrial site at Priolo in Sicily into a biorefinery, and a chemical recycler plant for plastics. The Italian energy ministry has recently approved the application for the project. It will be built on the site of Eni's decommissioned ethylene plant. Eni is implementing this move as part of its plan to revamp its chemical business.

Sources: Swiss gold refining plans add sparkle to Trump's trade deal

Two people with knowledge of the situation say that Switzerland wants to build a gold refinery or increase its processing capacity in the United States as part a plan to lower U.S. tariffs. Donald Trump imposed 39% tariffs on Swiss imports as a result of the U.S.-Swiss trade deficit on August 7, 2018. Switzerland had scrapped its industrial tariffs in January. The main reason for the goods trade deficit with Switzerland is due to Swiss exports, including gold and chemicals.

VCI: German chemical industry runs at its lowest capacity for more than 30 Years

The German Chemical Industry Association said Wednesday that its capacity utilization in the second quarter was at its lowest level for more than 30 year as sales and prices fell due to uncertainty surrounding U.S. Tariffs. VCI reported that the German chemical industry only operated at 72% of full capacity in the period April-June, which is the lowest level seen since 1991 and far below the level needed to break even. VCI said that pull-forward effects on business with the United States decreased throughout the period of April-June…

German chemical lobby VCI reports quarterly sales and production decline amid tariff uncertainty

The German chemical industry association reported on Wednesday that the second-quarter production, sales and prices had declined, citing uncertainty regarding U.S. tariff policies. VCI said that pull-forward effects on business with the United States decreased throughout the period of April-June, because exports were brought forward to prepare for tariffs on European goods. The overall production of the chemicals sector, including pharmaceuticals, fell by 3.8% from quarter to quarter. This is in contrast with the 6.7% quarterly increase between January and March.